Cancer in Medical Technology

Regular Yoga Practice Is Associated With Mindful Eating

... to a study led by researchers at Fred Hutchinson cancer Research Center. The study was prompted by ... behavior," said Kristal, associate head of the cancer Prevention Program in the Public Health Sciences ... a research dietitian in the Hutchinson Center's cancer Prevention Program. Fred ...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

... with KRAS wild-type metastatic colorectal cancer (mCRC). "We believe that these data ... with chemotherapy for M etastatic colorectal cancer to determine E fficacy) enrolled 1,183 ... reaching the nucleus, these signals instruct the cancer cell to reproduce and metastasize, leading ...

Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors

... RALEIGH, N.C., Aug. 5 /PRNewswire/ -- cancer Centers of North Carolina , an affiliate of ... radiation is delivered directly to the cancer target through the use of catheters, needles or ... can be delivered on an outpatient basis at cancer Centers of North Carolina's office, which ...

ARUP Laboratories Applauds FDA's Decision on the Value of KRAS-Mutation Testing in Colorectal Cancer

... "retrospective analyses of metastatic colorectal cancer trials have not shown a treatment benefit for ... not recommended for the treatment of colorectal cancer patients with these mutations. ARUP ... "In the United States, colorectal cancer is the third most common form ...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

... treatment of bone metastases in 1,776 advanced cancer patients with solid tumors (not including breast ... arms, as was overall survival and the time to cancer progression. "We are extremely pleased ... a clinically meaningful benefit for advanced cancer patients with solid tumors that have metastasized ...

Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome

... of blood stem cell precursors and induce cancer cell death in human leukemia cell lines. ... and developing small molecule drugs to treat cancer and inflammatory diseases. The company's most ... prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product ...

Project Zero Delay Accelerates Drug's Path to Clinical Trial

... of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to ... from The University of Texas M. D. Anderson cancer Center and pharmaceutical company AstraZeneca ... designed to safely accelerate development of new cancer drugs. In many cases that process takes about 12 ...

Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention

... in a Series Based on Presentations from Cervical cancer Prevention Forum Hosted by SGO CHICAGO, ... a series of four papers on a variety of cervical cancer issues and topics that were the focus of its Forum " The Future Strategies for Cervical cancer Prevention: What Do We Need to Do Now to ...

Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program

... levels and regimens of ProLindac monotherapy in cancer patients, provide additional data to support ... and extend the safety database. Two ovarian cancer patients have been enrolled in the study to date, ... recently announced data from a recurrent ovarian cancer trial that showed that ProLindac was more active ...

OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer

... International Association for the Study of Lung cancer (IASLC) 13th World Conference on Lung Cancer. The ... in patients with advanced non-small cell lung cancer (NSCLC), the combination of OPAXIO (paclitaxel ... studies support that OPAXIO metabolism by lung cancer cells may be influenced by estrogen, which could ...

British Woman Celebrates a Year of Living Cancer-Free

... fashion designer Joanne Scott went through a cancer treatment that changed her life -- and made ... cells could be the key to a new type of advanced cancer therapy. Doctors at the Royal Free ... if they are activated to fight the cancer. In cancer patients, however, the NK cells are not activated ...

Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk

... that women in New Jersey who take the breast cancer drug tamoxifen in conjunction with certain ... may be at a higher risk for a breast cancer recurrence. In May, Medco Health ... using tamoxifen to prevent a recurrence of breast cancer who also use certain selective serotonin reuptake ...

Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy

... from a clinical study showing patient-specific cancer vaccines derived from patients' own cancer cells and immune cells were well tolerated and ... was published in the June 2009 issue of cancer Biotherapy and Radiopharmaceuticals and was ...

First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center

... -- Earlier this month the University of Wisconsin cancer Center Riverview became the first medical ... Riverview Hospital, Wisconsin Rapids, the UW cancer Center Riverview is the first to treat skin cancer patients with the FDA-cleared Axxent(R) ...

Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs

... The purpose of the Phase III gastric cancer study is to evaluate the effect of IMC-1121B on ... survival of patients with metastatic gastric cancer following disease progression on standard ... Medical Officer Eric K. Rowinsky, M.D. "Gastric cancer is not only a major cause of mortality and ...

Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing

... medical officer of Poniard. "More than 1,100 cancer patients have received picoplatin in clinical ... that is in clinical development for multiple cancer indications, treatment combinations and by two ... profile relative to existing platinum-based cancer therapies. Results to date suggest that ...

National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness

... of Molecular Pharmacology at the National cancer Institute presented new preclinical research ... LLC in 2007. Published in the journal Molecular cancer Therapy (Mol cancer Ther 2009;8(7) July 2009; 1985-94), the ...

UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPar's Investigational Cancer Drug BSI-201

... III Follow-up Study to BiPar's Investigational cancer Drug BSI-201 Phase II of the trial ... M.D. , co-chair of the US Oncology Breast cancer Research Committee, associate director for ... for US Oncology and co-director of the Breast cancer Research Program at Baylor-Charles A. ...

Northern California Cancer Center's First-of-Its-Kind Research Reveals Low Socioeconomic Status Often Equals Poor Chance of Lymphoma Survival

... -- The Northern California cancer Center ( NCCC ) recently found that ... most common type of non-Hodgkin lymphoma, is a cancer of the immune system and white blood cells which affects men and women equally. The cancer involves the body's lymph nodes which fight ...

International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit

... -- Scientists at the Barbara Ann Karmanos cancer Institute's National Center for Vermiculite and ... likely to detect asbestos-related diseases and cancer at an earlier stage. Earlier detection will ... State University School of Medicine, and chief, cancer Surveillance Research at the Barbara Ann ...

Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC

... chemotherapy against human non-small cell lung cancer (NSCLC). The paper, entitled "Synergistic ... Chemotherapeutic Agents in Non-Small Cell Lung cancer Cells" appears online in the July 14, 2009 issue ... the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program ...

Velos, Inc. Releases Software to Support Cancer Centers With New Workflow and Content for NCI Clinical Trials Reporting Program

... of new system capabilities to ensure that the cancer center community can fulfill new registration requirements for the U.S. National cancer Institute (NCI) Clinical Trials Reporting ... to support the NCI and, at the same time, to help cancer centers work successfully with these new ...

Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center

... open for enrollment at Memorial Sloan-Kettering cancer Center in New York City. Oren Becher, MD, ... the Brain Tumor group at Memorial Sloan-Kettering cancer Center, will act as the study's Principal ... at AACR 2009 by investigators from the National cancer Institute demonstrated that single agent ...

University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test

... 9,000 American women are diagnosed with cervical cancer each year despite regular cervical screening. The ... samples taken from tumors in confirmed cervical cancer patients were analyzed using a prototype assay ... the last major gap in screening for cervical cancer and thus possibly saving thousands of lives," Dr. ...

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

... for the treatment of non-muscle-invasive bladder cancer that is currently undergoing Phase III clinical ... opportunity to expand our portfolio in bladder cancer treatment and enhance our late stage development ... Bioniche, given its understanding of the bladder cancer market and breadth of pharmaceutical industry ...

CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series

... Corporation (NYSE Amex: CVM ), a late stage cancer immunotherapy company, announced today that Dr. ... of Dr. Talor's presentation is: "Multikine: cancer Immunotherapy; how to make immunotherapy for cancer work" . In the presentation, Dr. Talor ...

Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer

... on the Primary Therapy of Early Breast cancer indicated for the first time that the Genomic ... of 43 European and US experts on early breast cancer treatment that emerged from the conference which ... It will soon be available as a product for cancer care centers equipped with a CE-marked, ...

Mayo Clinic Proceedings: A Comprehensive Review of Addiction to Prescription Painkillers Among Patients and Physicians

... and Behavioral Sciences, Memorial Sloan-Kettering cancer Center, New York, in "Issues in Long-Term Opioid ... to individuals who have chronic pain, both cancer and non-cancer related, anesthesiologists have ... Severe chronic pain includes that produced by cancer and such non-cancer conditions as back injury and ...

Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases

... metastases in 2,049 patients with advanced breast cancer met its primary and secondary endpoints and ... arms, as was overall survival and the time to cancer progression. "We are extremely pleased with ... complications of bone metastases in breast cancer patients better than the current standard of ...

Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story

... African-American breast, ovarian, and prostate cancer patients tend to die earlier than patients of ... look at the dialogue about the issue of race and cancer survival that's gone on over the years," says the ... author, Kathy Albain, M.D., a breast and lung cancer specialist at Loyola University's Cardinal ...

USC Keck School of Medicine's Dr. Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL-2 Molecule Therapeutic

... Development (RAID) program of the National cancer Institute (NCI) for his breakthrough ... award Dr. Epstein has received from the National cancer Institute. The NCI RAID program is a ... has elevated the disease to the sixth most common cancer in the United States. Approximately 60,000 ...

Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet

... of the largest efficacy trial of a cervical cancer vaccine is published today in The Lancet . The ... good news for primary prevention of cervical cancer as it indicates the vaccine could offer women additional protection against cervical cancer beyond what had at first been anticipated." ...

New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects

... in two new projects. These projects, focusing on cancer and inflammatory diseases, have a total budget of ... delivery platform for inflammatory diseases and cancer New molecular entities (NMEs) in the drug ... of kinase inhibitors in the treatment of cancer and chronic inflammatory diseases. "This approach ...

New Review on PROSTVAC(TM) Published by Key Investigators From NCI

... immune response that attacks prostate cancer cells. Conventional chemotherapy currently used to treat prostate cancer has limited survival rates and is often ... strategy is focused in three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's ...

/C O R R E C T I O N -- Agendia B.V./

... In the news release, "Agendia's Breast cancer Recurrence Test MammaPrint Included in ... , /PRNewswire/ -- Agendia's Breast cancer Recurrence Test MammaPrint Included ... 23 2009 - Agendia, a world leader in molecular cancer diagnostics, today announced the inclusion of its ...

Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation

... St. Jude Department of Oncology and an American cancer Society Professor. "It controlled CNS leukemia ... the National Institutes of Health, the American cancer Society F.M. Kirby Clinical Research ... work in finding cures and saving children with cancer and other catastrophic diseases. Founded by late ...

Agendia's Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations

... -- Agendia, a world leader in molecular cancer diagnostics, today announced the inclusion of its breast cancer recurrence test MammaPrint in St. Gallen's 2009 ... an adjunct to high-quality phenotyping of breast cancer in cases in which the indication for ...

Gene Findings Unlocking Reasons for Neuroblastoma Risk

... system, neuroblastoma is the most common solid cancer of early childhood and causes 15 percent of all childhood cancer deaths. "Only two years ago we had very ... M.D., chief of Oncology and director of the cancer Center at The Children's Hospital of ....

Alfacell Provides Shareholder Update

... of Pathology and Medicine; Director, Brander cancer Research Institute, New York Medical College , a ... candidate to be used as an adjunct to variety of cancer treatment protocols. In this capacity Onconase ... tumor types, including most common types such as cancer of breast, prostate, colon, ovary and lung." ...

Cancer Treatment Centers of America(R) Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells

... Therapy targets folate receptors found on cancer cells otherwise resistant to standard chemo ZION, Ill., June 17 /PRNewswire-USNewswire/ -- cancer Treatment Centers of America (CTCA) at ... Medical Center, a leading provider of innovative cancer care for patients living with complex and ...